Expansion Therapeutics, Inc.

10996 Torreyana Road
Suite 280
San Diego
California
92121
United States

Tel: 858-764-4290

Email: info@expansionrx.com

Show jobs for this employer

About Expansion Therapeutics, Inc.

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Based on exclusive worldwide rights to groundbreaking research from the laboratory of Matthew D. Disney, Ph.D., at The Scripps Research Institute, Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in San Diego, California and Jupiter, Florida.

YEAR FOUNDED:
2016

LEADERSHIP:
Co-Founder, President and CEO: Kevin M. Forrest, Ph.D.
Scientific Founder: Matthew D. Disney, Ph.D.
Scientific Advisor: Eric Wang, Ph.D.
Acting CMO: Brian Daniels, M.D.
Acting VP R&D Operations: Greg Korbel, Ph.D., M.B.A.
VP Chemistry: Tim Blizzard, Ph.D.
Head of Intellectual Property: John W. Wallen III, Ph.D., J.D.

PIPELINE:
Please click here for Expansion Therapeutics' pipeline.

3 articles with Expansion Therapeutics, Inc.